KRAS and cancer: The Hippo pathway is directly regulated by the transcription regulator YAP.[27] Previous reports indicated that YAP signaling impacts the development of drug resistance to various cancer therapies.[28, 29] We conducted RNA‐seq‐based transcriptome profiling of KRAS G12C inhibition sensitive NSCLC (NCI‐H358) cells treated with vehicle control, AMG510, IN10018, or the AMG510–IN10018 combination for 24 h.